Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
AVIR
Stock Latest News
The Fly
Atea Pharmaceuticals doses first patient in C-BEYOND, Phase 3 study
22h ago
AVIR
Premium
The Fly
Atea Pharmaceuticals cuts 25% of workforce, exploring partnerships
15d ago
AVIR
Premium
The Fly
Radoff-JEC Group nominates candidates to Atea Pharmaceuticals board
15d ago
AVIR
Premium
The Fly
Atea Pharmaceuticals issues statement regarding director nominations
19d ago
AVIR
Premium
The Fly
Atea Pharmaceuticals announces presentation of bemnifosbuvir preclinical data
22d ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Faces Challenges Amid Workforce Reductions and Cost-Cutting Efforts
1M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals’ Promising Earnings Call Highlights
1M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Advances HCV Program with FDA Approval
1M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals reports Q4 EPS (40c), consensus (29c)
1M ago
AVIR
Premium
Pre-Earnings
AVIR Upcoming Earnings Report: What to Expect?
1M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Appoints Arthur Kirsch as Director
1M ago
8K
AVIR
Premium
The Fly
Atea Pharmaceuticals appoints Arthur Kirsch to board of directors
1M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals to highlight 2025 strategic priorities
3M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals retains financial advisor to explore partnerships
4M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir
4M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals presents three HCV poster presentations at AASLD
5M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Advances in HCV Treatment Development
5M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals files $500M mixed securities shelf
5M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals Phase 3 SUNRISE-3 trial did not meet primary endpoint
7M ago
AVIR
Premium
The Fly
Atea Pharma publishes data on metabolic activation pathway of bemnifosbuvir
7M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals upgraded to Equal Weight from Underweight at Morgan Stanley
8M ago
AVIR
Premium
The Fly
Atea presents initial Phase 2 data for bemnifosbuvir, ruzasvir combination
10M ago
AVIR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
